FOSCHINI FULVIO,STAGNI MARCELLO,LUCIANI GIULIO,ROY PIERRE
申请号：
IN2972CHN2014
公开号：
IN2972CHN2014A
申请日:
2014.04.21
申请国别(地区):
IN
年份:
2015
代理人:
摘要：
The present invention relates to an improved formulation of an ophthalmic composition containing riboflavin as cross linking agent of corneal collagen administered by corneal iontophoresis able to guarantee an increased capacity of permeation of riboflavin of the corneal stroma and therefore greater therapeutic efficacy in the treatment of keratoconus.
